Assessment of variations in control of asthma over time

Control and severity of asthma are two different but complementary concepts. The severity of asthma could influence the control over time. The aim of this study was to demonstrate this relationship. A total 365 patients with persistent asthma (severity) were enrolled and followed-up prospectively. Data were analysed using a continuous time homogeneous Markov model of the natural history of asthma. Control of asthma was defined according to three health states which were qualified: optimal, suboptimal and unacceptable control (states 1, 2 and 3). Transition forces (denoted λij from state i to state j) and transition probabilities between control states were assessed and the results stratified by asthma severity were compared. Models were validated by comparing expected and observed numbers of patients in the different states. Transition probabilities stabilised between 100–250 days and more rapidly in patients with mild-to-moderate asthma. Patients with mild-to-moderate asthma in suboptimal or unacceptable control had a high probability of transition directly to optimal control. Patients with severe asthma had a tendency to remain in unacceptable control. A Markov model is a useful tool to model the control of asthma over time. Severity modified clearly the health states. It could be used to compare the performance of different approaches to asthma management.

[1]  R. Hill,et al.  Description and evaluation , 1976 .

[2]  D. Cockcroft,et al.  Asthma control versus asthma severity. , 1996, The Journal of allergy and clinical immunology.

[3]  J. Bousquet,et al.  Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. , 1987, The Journal of allergy and clinical immunology.

[4]  N. Pride,et al.  Clinical assessment of patients. , 1998, The European respiratory journal. Supplement.

[5]  J. Bousquet,et al.  Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.

[6]  P. Barnes,et al.  Changes in sputum eosinophils predict loss of asthma control. , 2000, American journal of respiratory and critical care medicine.

[7]  C. Jenkins,et al.  Diurnal variability—time to change asthma guidelines? , 1999, BMJ.

[8]  Third Expert Panel on theDiagnosis,et al.  Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma , 1997 .

[9]  G H Guyatt,et al.  Development and validation of a questionnaire to measure asthma control. , 1999, The European respiratory journal.

[10]  J. Kalbfleisch,et al.  The Analysis of Panel Data under a Markov Assumption , 1985 .

[11]  L. Boulet,et al.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[12]  B Wallaert,et al.  Assessment of the severity of asthma by an expert system. Description and evaluation. , 1995, American journal of respiratory and critical care medicine.

[13]  S. Durham,et al.  Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness. , 1992, The American review of respiratory disease.

[14]  J F Lawless,et al.  Multi-state Markov models for analysing incomplete disease history data with illustrations for HIV disease. , 1994, Statistics in medicine.

[15]  J. Vandenbroucke,et al.  Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. , 1999, American journal of respiratory and critical care medicine.

[16]  Barrett T. Kitch,et al.  Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model. , 2001, The Journal of allergy and clinical immunology.

[17]  J. Bousquet,et al.  Is overall asthma control being achieved? A hypothesis-generating study. , 2001, The European respiratory journal.

[18]  G. Crompton,et al.  Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. , 2001, The European respiratory journal.

[19]  Pierre Ernst,et al.  Canadian asthma consensus report, 1999 , 1999 .

[20]  J. Daurès,et al.  Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis , 1999, British Journal of Cancer.

[21]  J. Daurès,et al.  [Modeling asthma evolution by a multi-state model]. , 2000, Revue d'epidemiologie et de sante publique.

[22]  A. Buist,et al.  Association of asthma control with health care utilization and quality of life. , 1999, American journal of respiratory and critical care medicine.

[23]  D. Pfeffermann,et al.  Small area estimation , 2011 .

[24]  J. Ward,et al.  Statistical analysis of the stages of HIV infection using a Markov model. , 1989, Statistics in medicine.